These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29878965)

  • 1. Effects of the use of neuromuscular blocking agents on acute respiratory distress syndrome outcomes: A systematic review.
    Paramore S
    J Am Assoc Nurse Pract; 2018 Jun; 30(6):327-332. PubMed ID: 29878965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular blocking agents for acute respiratory distress syndrome.
    Torbic H; Duggal A
    J Crit Care; 2019 Feb; 49():179-184. PubMed ID: 30396789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Lyu T; Lee YS; Dhanvijay S; Freebairn R
    Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 5. Paralytics in critical care: not always the bad guy.
    Forel JM; Roch A; Papazian L
    Curr Opin Crit Care; 2009 Feb; 15(1):59-66. PubMed ID: 19186410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.
    Rudolph MW; Slager S; Burgerhof JGM; van Woensel JBM; Alffenaar JC; Wösten-van Asperen RM; de Hoog M; IJland MM; Kneyber MCJ;
    Trials; 2022 Jan; 23(1):96. PubMed ID: 35101098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis.
    Torbic H; Krishnan S; Harnegie MP; Duggal A
    Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
    Shao S; Kang H; Tong Z
    BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis.
    Li Bassi G; Gibbons K; Suen JY; Dalton HJ; White N; Corley A; Shrapnel S; Hinton S; Forsyth S; Laffey JG; Fan E; Fanning JP; Panigada M; Bartlett R; Brodie D; Burrell A; Chiumello D; Elhazmi A; Esperatti M; Grasselli G; Hodgson C; Ichiba S; Luna C; Marwali E; Merson L; Murthy S; Nichol A; Ogino M; Pelosi P; Torres A; Ng PY; Fraser JF;
    Crit Care; 2022 May; 26(1):141. PubMed ID: 35581612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.
    Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y
    Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
    Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
    Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
    Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
    J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.
    Hua Y; Ou X; Li Q; Zhu T
    PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic evaluation of neuromuscular blocking agents on prognosis of patients with moderate to severe acute respiratory distress syndrome].
    Gao ZW; Zhao HM; Sun QS; Sun H; Huang YZ; Zheng P
    Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3819-3825. PubMed ID: 31874521
    [No Abstract]   [Full Text] [Related]  

  • 17. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.
    Bourenne J; Hraiech S; Roch A; Gainnier M; Papazian L; Forel JM
    Ann Transl Med; 2017 Jul; 5(14):291. PubMed ID: 28828366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of paralytics in patients with acute respiratory distress syndrome.
    Hraiech S; Dizier S; Papazian L
    Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC
    N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A meta-analysis of the effect of neuromuscular blocking agents on oxygenation in patients with acute respiratory distress syndrome].
    Gao ZW; Li C; Chen H; Xie JF; Liu L; Yang Y
    Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):86-94. PubMed ID: 34979776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.